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Detection of virulence gene belonging to cag 
pathogenicity island in Helicobacter pylori isolates 
after multiple unsuccessful eradication therapy in 
Northwest Croatia
Abstract
Background: Some of the genes belonging to cag pathogenicity island 
(cagPAI) in Helicobacter pylori were found to be associated with an in-
creased severity of gastric mucosal inflammation that might lead to the devel-
opment of gastroduodenal disease.
Aim: The aim of our study was to define a group of patients based on the 
frequency of virulence genes of cagPAI island and comparison with pathohis-
tological alterations of gastric mucosa who need to be subjected to further 
eradication therapy after previous unsuccessful eradication therapy and in 
spite of benign endoscopic findings.
Material and methods: In total 103 H. pylori isolates were analysed. 
Genes encoding virulence factors were detected by PCR with primers for 10 
loci in cagPAI: Apcag (cagA promotor region), cagA1, cagA2, cagA3, 
cagM, cagT, cagE, LEC, tnpA and tnpB. The patients who provided isolates 
were classified into three clinical categories: non-ulcer dyspepsia (n=69), ero-
sio/ulcus ventriculi (n=22) and erosio/ulcus duodeni (n=12).
Results: 16 strains (15.5%) were negative for all tested genes. 87 (84.5%) 
of the isolates had parcially deleated cagPAI. None of the isolates possessed all 
10 genes. The frequency of single cagPAI genes were as follows: Apcag 63.1%, 
cagA1 71.8%, cagA2 69.9%, cagA3 5.8%, cagM 71.8%, cagE 75,7%, 
cagT 68%, tnpA 9.7%, tnpB 7.8% i LEC 48.5%.
No statistically significant difference was observed between the presence of 
any cagPAI genes and endoscopic diagnosis (p>0.16). The presence of CagA2, 
Apcag and cagM showed statistically significant correlation with higher 
level of patohistological parameters of gastritis (p<0.05).
Conclusions: H. pylori isolates with positive cagA, Apcag and cagM 
genes are correlated to higher degree of patohistological lesions of gastric mu-
cosa; without statistically significant correlation with endoscopic diagnosis.
INTRODUCTION
Many studies have confirmed the role of H. pylori in the develop-ment of chronic gastritis, gastric and duodenal ulcer and the 
ethiological role in the pathogenesis of gastric carcinoma and mucosa-
associated lymphoid tissue (MALT) lymphoma.
H. pylori possess many virulence genes; one of them is cag pathogenic-
ity island (cagPAI) (1). CagPAI is since its discovery the most analysed 
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segment of H. pylori genome. It is approximately 40 kilo-
base pairs region of H. pylori chromosome and contains 
around 30 genes divided into region I and II. CagPAI is 
defined as intact if all genes are present, parcially deleated 
as presence of several genes and negative (deleated) if there 
are no genes at all (2). Many studies report correlation 
between presence of intact cagPAI, partially deleated and 
deleated cagPAI and clinical outcome. Some authors cor-
relate intact cagPAI with severe gastroduodenal diseases, 
with higher grade of chronic gastritis and premalignant 
lesions of gastric mucosa. (1, 3–4), while partially de-
leated and deleated cagPAI are associated with milder 
forms of gastroduodenal disease and lower grade of path-
ological alternations of gastric mucosa (5–6). On the 
contrary, some of the authors did not find correlation be-
tween cagPAI and gastroduodenal disease (7). CagPAI 
encodes multiple structural components of bacterial type 
IV secretion system (T4SS). T4SS translocates cagA pro-
tein directly to the cytosol of the gastric epitelium where 
it gets tyrosin phosphorylated by Src-family kinases and 
becomes able to alter the host cell functions leading to 
malignant transformation (2).
CagA gene is located in the region I of cagPAI and is 
considered to be the marker of this region. CagA positive 
isolates are associated with more severe clinical features 
in many studies. However, there are contradictory results 
in the references regarding these studies.
CagE is also located in the region I and is necessary to 
induce production of interleukin IL-8. Some authors con-
sider cagE gene to be better marker of cagPAI region com-
pared to cagA and more useful in monitoring the progress 
of H. pylori induced gastric disease. CagT gene is a mark-
er of cagII region and some studies connect it with more 
severe clinical disease (8). LEC (left terminal end of cagII) 
is not necessary for translocation of cagA into the host cell 
or induction of interleukin IL8. It is associated with pep-
tic ulcer and adenocarcinoma. Some of the study found 
connection of tnpA gene with peptic ulcer (9).
There are no published studies on the presence of H. 
pylori virulence genes in Croatia. Considering quite large 
number of patients with multiple unsuccessful eradication 
therapy, in spite of lack of clinical symptoms and benign 
endoscopic result, there is a question to pose whether to 
insist on eradication or not.
The aim of our study was to detect virulence genes of 
H. pylori just in these patients as a possible predictors of 
future severe gastroduodenal diseases, by comparing it 
with clinical and pathohistological results.
MATERIAL AND METHODS
Patients
The study analysed gastroscopic test results and bioptic 
specimens of gastric mucosa with positive H. pylori culture 
in 103 patients examined during routine, clinical gastro-
duodenoscopies in the endoscopic laboratory of the Uni-
versity Hospita Merkur in Zagreb during the period 
2008.–2012. Microbiological and molecular analysis was 
performed at the Department for Clinical and Molecular 
Microbiology of the University Hospital Center in Zagreb 
and pathohistological testing of the gastric biopsy speci-
mens at the Department for Pathology of University Hos-
pital Merkur. The study was approved by the Ethical Co-
mittee of the University Hospital Center Zagreb and 
University Hospital Merkur. The patients had signed the 
informed consent. Twenty-six men and seventy-seven 
woman in the age range of 28 to 80 years were included 
in the study. All patients were previously treated with 
eradication therapy for H. pylori. According to the endo-
scopic finding patients were classified in three groups: non 
ulcer dyspepsia (NUD), erosio/ulcus ventriculi (EUV), 
erosio/ulcus duodeni (EUD).
Bacterial culture
The biopsy specimens (one from corpus and one from 
antrum) were transported in tioglicolate broth, homog-
enized and seeded on Columbia agar with addition of 7% 
horse blood and Helicobacter pylori Selective Supplement 
SR 0147E (Oxoid) for cultivation of H. plyori. The plates 
were incubated in microaerophylic atmosphere with 
100% humidity for 3–5 days. Identification was done 
based on macromorphology, micromorphology and bio-
chemical testing (oxidase, urease, catalase). The strains 
were stored at –80°C in brucela broth with 10% glycerol.
DNA extraction
Extraction of chromosomal DNA was performed with 
commericial kit: High Pure PCR Template Preparation 
Kit, Version 16 (Roche Diagnostics Gmbh, Mannheim, 
Germany) according to the manufacturer’s recommenda-
tion. The DNA was stored at –20ºC until used for mo-
lecular studies.
PCR amplification
PCR was used to detect the following genes: cagA1, 
cagA2, cagA3, cagE, cagM, cagT, cagA promotor region (Ap-
cag), tnpA, tnpB and LEC using primers and conditions 
shown in Table 1. (10–14). A set of primers P1 and P2 that 
amplified a 26 kDa antigen (Ag) gene present in all strains 
of H. pylori was used as a positive PCR control. All PCR 
reactions were performed using a GeneAmpC PCR System 
9700 (A6B Applied Biosystems. PCR products were visu-
alised by electrophoresis in in 2% agarose gel, after staining 
with ethidium bromide and examined in UV transillumi-
nator. A 100 bp DNA ladder (Sigma) was used as a size 
marker. Reference strains 47164 and 17874 (Culture col-
lection, University of Goethenburg) were used a positive 
control.
Histology
Specimens for pathohistological analysis were fixed in 
a standard 4% neutral buffered formalin, and cut into 
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slides. Slides were routinely stained ana analysed accord-
ing to modified Sydney classification of gastritis (15). 
Metaplasiae were scored as yes or no, concerning that 
none of the patients had incomplete metaplasia of II or III 
grade. All metaplasias were of the I grade.
Statistical analysis
Age and complex scores were expressed as mean and 
standard deviation (SD). Comparison for complex scores 
were done using Student’s t-test. Categorical variables 
were presented as frequencies (%). The comparison be-
tween subgroups for categorical variables were done using 
c test or Fischer exact test with the calculation of odds 
ration (OR) together with 95% confidence intervals (CI). 
Logistic regression analysis was used to calculate OR 
(95%CIs) for the association of the presence of individu-
al genes with complex scores (OR was calculated for the 
1-point change in complex score). A P value of <0.05 was 
considered statistically significant for all tests performed. 
The analysis was performed using STATISTICA, version 
10. (StatSoft, Inc., OK, USA).
RESULTS
In the study were included 103 patients: 25 men and 
78 woman in the age range of 28 to 81 years, with me-
dian age of 55.8 years (SD±11.8). According to endo-
scopic results patients were classified into three groups: 68 
(66%) with non-ulcer dyspepsia (NUD), 22 (21.4%) with 
erosio/ulcus ventriculi (EUV), and 13 (12.6%) with ero-
sio/ulcus duodeni (EUD).
Out of 103 H. pylori isolates 16 (15.5%) had deleated 
cagPAI, and 87 (84.5%) partially deleated cagPAI. None 
of the isolates had intact cagPAI. There was no statisti-
cally significant difference in the distribution of cagPAI 
either according to the gender (c2=0.005, df=1, p= 0.941) 
or according th the endoscopic diagnosis (c2=1.142 df=2, 
p= 0.565) as shown in Table 2.
The frequency of particular genes was as follows: cagA1 
71.8%, cagA2 69.9%, cagA3 5.8%, cagE 75.7%, cagM 
71.8%, tnpA 9.7%, cagT 68%, Apcag 63.1%, LEC 48.5% 
and tnpB 7.8% as shown in Figure 1.
Table 1. Primers used in this study
Gene Primer Primer sequence Amplicon size Annealing temp. Reference
cagM Cag 5 ACAAATACAAAAAAGAAAAAGAGGC 586 bp 53 °C 10
  Cag 6 ATTTTTCAACAAGTTAGAAAAAGCC      
tnpA Cag10 ATCAGTCCAAAAAGTTTTTTCTTTCC 344 bp 53 °C 10
  Cag11 TAAGGGGGTATATTTCAACCAACCG      
tnpB Cag 8 ACAAATACAAAAAAGAAAAAGAGGC 569 bp 53 °C 10
  Cag 9 AGCTAGGGAAAAATCTGTCTATGCC      
cagA2 CAG1 AGACAACTTGAGCGAGAAAG 320 bp 53 °C 11
CAG-2 TATTGGGATTCTTGGAGGCG 
cagE CagE-F1 ACAAATACAAAAAAGAAAAAGAGGC 329 bp 52 °C 12
  CagE-R1 GAAGTGGTTAAAAAATCAATGCCCC      
cagT CagT-F1 CCATGTTTATACGCCTGTGT 301bp 52 °C 12
  CagT-R1 CATCACCACACCCTTTTGAT      
cagA3 CagA-F1  AACAGGACAAGTAGCTAGCC 701 bp 52 °C 12
  CagA-R1 TATTAATGCGTGTGTGGCTG      
cagA1 CagA-F2 ACAAATACAAAAAAGAAAAAGAGGC 349 bp 52 °C 12
  CagA-R2 CTGCAAAAGATTGTTTGGCAGA      
Apcag CagA-R2 CTGCAAAAGATTGTTTGGCAGA 730 bp 52 °C 12
  AP-F1 GTGGGTAAAAATGTGAATCG      
LEC LEC-F1 ACATTTTGGCTAAATAAACGCTG 320-550 bp 55 °C 13
  LEC-R1 TCTCCATGTTGCCATTATGCT      
Ag P1 TGGCGTGTCTATTGACAGCGAGC 298 bp 57 °C 14
  P2 CGTGCTGGGCATACTTCACCATG      
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Pathohistological analysis of antrum revealed inflam-
mation in all patients (100%), activity was found in 66% 
of the patients, atrophy in 6.8% and intestinal metaplasia 
in 24.3%. All patients had inflammation in the corpus. 
Activity was found in 62.2% of the patients. Atrophy was 
present in 4.9% and metaplasia in 13.6% of the patients. 
Table 3. shows the distribution of different grades of pa-
thohistological parameters of gastritis in the antrum and 
corpus.
There was no statistically significant difference in 
pathohistological lesions between the patients with par-
cially deleated cagPAI and those with deleated cagPAI 
(p>0.05 for all parameters describing pathohistological 
lesions).
The presence of CagA2 was significantly related to the 
higher grade of inflammation of antrum (c2=6.872, df=2, 
p=0.032), with increased density of H. pylori in the corpus 
(c2=16.7, df=3, p=0.001), and with higher total score for 
the corpus (mean±SD=4.1±1.5 for CagA2+, 3.3±1.4 for 
CagA2, t=2.687, p=0.008) as shown in Table 4.
The presence of Apcag was significantly correlated with 
higher inflammatory score of antrum (Apcag+:mean± 
SD=4.9±1.7; Apcag-: 4.0±1.7; t=2.332, p=0.022) (Table 4).
The presence of cagM was related to the higher densitiy 
of H. pylori in the corpus (c2=9.864, df=3, p=0.020). and 
higher total score for the corpus (CagM+: 
mean±SD=4.1±1.6; CagM-: 3.4±1.4;t=2.021, p=0.046) 
(Table 4).
The presence of cagT and LEC was related to less fre-
quency of antrum atrophy (cagT, c2=5.35, df=1, p=0.021).
Correlation between any of ten cagPAI genes and en-
doscopic diagnosis (p>0.16 for all) was not found in this 
study.
DISCUSSION
In our study, we amplified 10 H. pylori genes in order 
to characterize cagPAI. Intact cagPAI was not found but 
there was 84.5% parcially deleated, and 15.5% completely 
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Figure 1. Percentage and number of positive cagPAI genes from H. 
pylori isolates (N=103)
Table 2. Correlation of cagPAI and endoscopic diagnosis
Endoscopic  
diagnosis
Partialy deleted
cagPAI
Completely deleted
cagPAI
EUV 22 (21.4%) 17 (77.3%) 5 (22.7%)
EUD 13 (12.6%) 11 (84.6%) 2 (15.4%)
NUD 68 (66.0%) 59 (86.8%) 9 (13.2%)
EUV – erosio/ulcus ventriculi; EUD – erosio/ulcus duodeni; NUD – 
non-ulcer dyspepsia.
Table 3. Pathohistological characteristics of the patients (n=103)*
Characteristics Positivity Score No (%) Mean (SD)
A
nt
ru
m
Activity 
PMN 68 (66%)
0
1
2
3
35 (34.0)
50 (48.5)
15 (14.6)
3 (2.9)
Inflammation 103 (100%)
1
2
3
35 (34.0)
65 (63.1)
3 (2.9)
Inflammatory 
score 2.5 (1.1)
Atrophy 7 (6.8%)
0
1
96 
(93.2)
7 (6.8)
Metaplasia 25 (24.3%)
0
1
78 (75.7)
25 (24.3)
H. pylori 92 (89,3%)
0
1
2
3
11 (10.7)
33 (32.0)
34 (33.0)
25 (24.3)
Total score 4.5 (1.8)
C
or
pu
s
Activity 
PMN
64 
(62.2%)
0
1
2
39 (37.9)
53 (51.5)
11 (10.7)
Inflammation 103 (100%)
1
2
3
55 (53.4)
43 (41.7)
5 (4.9)
Inflammatory 
score 2.2 (1.0)
Atrophy 5 (4,9%)
0
1
2
98 (95.1)
4 (3.9)
1 (1.0)
Metaplasia 14 (13,6%)
0
1
89 
(86.4)
14 (13.6)
H. pylori 99 (96,1%)
0
1
2
3
4 (3.9)
61 (59.2)
25 (24.3)
13 
(12.6)
Total score 3.8 (1.5)
Total score 
antrum+corpus 8.4 (2.5)
*Accoridng to the Updated Sydney system classification with metapla-
sia absent=0 and present=1, PMN= Polymorph-nuclear cells
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deleated. In contrast, in the study done in Mexico which 
included 11 genes, there was 90% of intact cagPAI, 4% of 
parcially delated and 6% of completely deleated (16).
We want to emphasise that there is disconcordance be-
tween different studies in the number of cagPAI genes 
analysed, and the definition of intact, deleated and par-
cially deleated cagPAI. Most studies analysed limited num-
ber of genes. Salih et al. analyzed 4 genes of cagPAI and 
reported 42.1% of intact, 39.5% of partially deleated and 
18.4% completely deleated cagPAI and the correlation of 
intact cagPAI and duodenal ulcer (17). Baghaei et al. ana-
lyzed three genes and reported 17% of intact cagPAI, 62% 
of partially deleated and 20% of completely deleated in 
Iran population (8). Nygen et al. analysed 30 genes with 
the same number of strains and similar endoscopic diag-
nosis as in our study and found 88% of intact, and 12% 
of parcially deleated in Vietnam population (18). Based on 
bibliographical data it is evident that the frequency of in-
tact cagPAI varies depending on the geographic area.
Results of our study did not demonstrate any correla-
tion between deleated and partially deleated cagPAI and 
either endoscopic diagnosis or pathohistological lesions. 
It is hard to explain wheter our results reflect the situation 
in our geographic region or if they are related to a spe-
cific category of patients with predominant non-ulcer 
dyspepsia. The study from Maeda et al. from Japan con-
firmed our observation that partially deleated cagPAI is 
associated with non-ulcer dyspepsia in contrast with in-
tact cagPAI found in patients with gastric cancer (19). We 
do not have the data for different categories of patients 
with other grades of gastroduodenal disease. This is the 
first study of genotyping of cagPAI in Croatia. The future 
studies should be focused on genotyping of cagPAI in 
Croatian patients with severe gastroduodenal disease.
CagA is considered to be a marker of cagPAI region 
(20). In our study we analysed three different segment of 
cagA gene. cagA1 segment close to the promoter region, 
middle segment cagA2 and right end cagA3. While the 
rate of cagA1 and cagA2 positivity was similar (71.8%) and 
(69.9%) respectively, the frequency of cagA3 was low 
(5.8%). The frequent deletion of cagA3 compared to cagA1 
and cagA2 in the control strains reported by Matar et al. 
was attributed to decreases pathogenicity (9). Prevalence 
of cagA positive strains differs between the countries and 
is the highest in East Asia (90%), Japan (100%) (21) and 
Bulgaria (84.9%) (22). The moderate prevalence was 
found in Iran (62%) (23), Slovenia (61%) (24), Columbia 
(64%) (21), Turkey (49%) (25), Equador (46%) (26) and 
Portugal (31.8%) (27). The previous studies on H. pylori 
in Croatia reported the prevalence of serum antibodies 
Table 4. Association of H. pylori cagPAI genes with pathohistological changes of gastric mucosa
Pathohistology
Grade Negative Positive Statistics P-value OR (95% CI)
cagA2
Inflammation, antrum
1
2
3
16
15
0
19
50
3
c2=6.872 0.032 2.941 (1.216–7.217)for grade 1 vs. 2/3
H. pylori, corpus
0
1
2
3
3
25
1
2
1
36
24
11
c2=16.700 0.001 15.02 (4.558–67.12)for grade 0/1 vs. 2/3
Total score, corpus Mean±SD 3.3±1.4 4.1±1.5 t=2.687 0.008 3.841 (1.531–9.638)
CagM
H. pylori, corpus
0
1
2
3
1
24
2
2
3
37
23
11
c2=9.864 0.020 8.665 (2.621–38.73)for grade 0/1 vs. 2/3
Total score, corpus Mean±SD 3.4±1.4 4.1±1.6 t=2.021 0.046 3.259 (1.293–8.215)
cagT
Atrophy, antrum 01
28
5
68
2 c2=5.352 0.021 0.165 (0.030–0.918)
Apcag
Inflammatory score, antrum Mean±SD 2.2±1.0 2.7±1.1 t=2.283 0.025 2.448 (1.285–26.008)
Total score, antrum Mean±SD 4.0±1.7 4.9±1.7 t=2.332 0.022 2.349 (1.027–5.374)
LEC
Atrophy, antrum 01
46
7
50
0 0.016* 0 (0–0.524)
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against bacterial virulence antigens p120 (CagA- cyto-
toxin associated antigen) of 91.3% in the group of patients 
with severe gastroduodenal diseases (28). In our study the 
prevalence of cagA was not statistically significantly cor-
related with clinical diagnosis which is in concordance 
with the study of Strauss et al. (81% positive) (29) but 
different from the study of Marie M et al. (62% positive) 
where the presence of cagA was correlated with gastritis 
and peptic ulcer (30). In our study the presence of cagA 
was correlated with higher degree of inflammation in the 
gastric mucosa, particularly in antrum (p=0.001). In the 
previous study from Croatia p120 (cagA) seropositivity 
was significantly more often present in patients with 
higher activity grade in the antrum (28). These results are 
in concordance with other studies which proved that cagA 
enhances accumulation of neutrophiles, determined as 
inflammatory score and according to some studies in-
duces the production of interleukine IL-8 (17). These 
results are confirmed by studies from Iran (31). No cor-
relation between cagA and cagE and clinical outcome in 
Iran patients was found (32). In our study cagA2 is re-
lated to the higher density of H. pylori (p=0.001) and this 
correlation was confirmed by other authors (33–35). 
However, some studies did not find any significant rela-
tionship between cagA positivity and H. pylori density, 
neutrophil activity, lymphoid aggregation in lamina pro-
pria and glandular atrophy in the biopsies, but significant 
association was detected with severe chronic gastritis (23). 
The frequency of cagE in our study was higher than of 
cagA (75.7% vs 71.8%). This is in agreement with some 
studies which consider cagE to be a better marker of cagI 
region than cagA (9, 36). We did not find any association 
between cagE and endoscopic diagnosis and pathohisto-
logical lesions which is in agreement with the results from 
a study conducted in Portugal where cagE is more preva-
lent than cagA (27). Modena at al. have not found asso-
ciation between cagE and clinical outcome (37), contrari-
ly to the studies which described higher frequency of cagE 
and sever gastroduodenal disease such as ulcer and gastric 
cancer, than in gastritis (3). CagT as a marker of cagII 
region was identified in 68% of our isolates and was as-
sociated with decreased frequency of antrum atrophy 
without any correlation with clinical diagnosis. However, 
some authors did not report correlation with either clini-
cal diagnosis or pathohistological alterations of gastric 
mucosa (8). Mattar et al. reported that 98% of the pa-
tients with ulcer disease retained cagT gene (9), while the 
isolates with deleted cagT were more frequent in the pa-
tients with chronic gastritis compared with peptic ulcer 
disease or gastric cancer in Japanese population (12). 
Fisher et al. claim that the patients with H. pylori lacking 
cagT have disfunctional T4SS and are unable to translo-
cate cagA protein into the host cell (38). In the study from 
England the majority of ulcer disease strains retained the 
cagT and cagE gene (39). In our study cagM with the 
prevalence of 71.8% was associated with increased den-
sity of H. pylori in corpus and higher total score for cor-
pus, but unrelated to the endoscopic diagnosis. Matar et 
al. correlated this gene with higher grade of gastritis and 
peptic ulcer disease (9). LEC (left end of cagII) was found 
in 48.5% of our isolates and was related to the lower 
prevalence of antrum atrophy. The LEC is rearranged 
more frequently in isolates linked to severe pathology (40).
This study comprised the patients without successfull 
eradication of H. pylori infection after multiple antibiotic 
courses in spite of the fact that antimicrobial therapy was 
after one or two unsuccessful therapeutic outcomes created 
in accordance with antimicrobial susceptibility testing.
The most patients had normal or harmless endoscopic 
result (non-ulcer dispepsia). Although pathological al-
terations did not point out to the danger of premalignant 
lesions our study found a high frequency of cagA, ApCag, 
cagT and cagM genes in the isolates recovered from the 
patients included in the study. The correlation between 
the presence of these genes and higher degree of serious 
pathohistological lesions in gastric mucosa was observed. 
According the the results of the present study it could be 
concluded that the presence of these genes can predispone 
for the development of ulcer, premalignant or malignant 
diseases. Thus, insisting on eradication of H. pylori in spite 
of harmless endoscopis and histological results should be 
considered as the only correct choice.
In spite of the fact that application of molecular diag-
nostics in detection of virulence genes is too expensive and 
not recommended for routine diagnostic, it should have 
a role in selected patients with unsuccessful eradication 
therapy with usual therapeutic protocols.
Moreover, the genomic profiles generated in this study 
may be useful for interlaboratory comparisons and are 
suitable for storage in epidemiological databases for com-
parative analyses. Our study has been focused on a spe-
cific group of patients isolates and may be representative 
for isolates from patients in this geographic region in 
Croatia. Future studies are needed to involve other disease 
specific strain group with appropriate controls.
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